Literature DB >> 18385443

Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.

Jérôme LeGoff1, Philippe Mayaud, Gérard Gresenguet, Helen A Weiss, Khonde Nzambi, Eric Frost, Jacques Pepin, Laurent Belec.   

Abstract

The performances of commercial enzyme-linked immunosorbent assays (ELISAs) in detecting herpes simplex virus type 2 (HSV-2) antibodies have been inconsistent for African and human immunodeficiency virus (HIV)-positive populations. We compared the performances of the HerpeSelect and Kalon glycoprotein G2 ELISAs for patients with genital ulcer disease in Ghana and the Central African Republic. Sera from 434 women were tested with the HerpeSelect assay, and a subsample (n = 199) was tested by the Kalon assay. Ulcer swabs and cervicovaginal lavage samples were tested for HSV-2 DNA by PCR. HSV-2-seronegative women with detectable genital HSV-2 DNA were retested for HSV-2 antibodies 14 and 28 days later by the two ELISAs. A total of 346 (80%) women were positive by HerpeSelect at baseline, and 225 (54%) had detectable genital (lesional or cervicovaginal) HSV-2 DNA. Sixty-six (19%) HerpeSelect-positive samples had low-positive index values (1.1 to 3.5), and 58% of these samples had detectable genital HSV-2 DNA. Global agreement between the two serological assays was 86%. Concordance was high (99%) for sera that were negative by HerpeSelect or had high index values (>3.5). Defining infection detected by HSV-2 DNA PCR and/or Kalon assay as true infection, 71% of sera with low-positive index values were associated with true HSV-2 infection. Twenty-five women were identified as having nonprimary first-episode genital HSV-2 infection. Rates of HSV-2 seroconversion at day 14 were 77% (10/13 patients) by HerpeSelect assay and 23% (3/13 patients) by Kalon assay, with four additional seroconversions detected by Kalon assay at day 28. HIV serostatus did not influence assay performance. Low index values obtained with the HerpeSelect assay may correspond to true HSV-2 infection, in particular to nonprimary first episodes of genital HSV-2 infection, and need to be interpreted in the context of clinical history.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385443      PMCID: PMC2446869          DOI: 10.1128/JCM.02332-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Diagnostic polymerase chain reaction for donovanosis.

Authors:  J Carter; F J Bowden; K S Sriprakash; I Bastian; D J Kemp
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

2.  Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.

Authors:  Rhoda Ashley-Morrow; Elizabeth Krantz; Anna Wald
Journal:  Sex Transm Dis       Date:  2003-04       Impact factor: 2.830

3.  Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers.

Authors:  K A Orle; C A Gates; D H Martin; B A Body; J B Weiss
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Comprehensive PCR-based assay for detection and species identification of human herpesviruses.

Authors:  G Johnson; S Nelson; M Petric; R Tellier
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Authors:  Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.

Authors:  Eddy van Dyck; Anne Buvé; Helen A Weiss; Judith R Glynn; David W G Brown; Bénédicte De Deken; John Parry; Richard J Hayes
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India.

Authors:  Steven J Reynolds; Arun R Risbud; Mary E Shepherd; Jonathan M Zenilman; Ronald S Brookmeyer; Ramesh S Paranjape; Anand D Divekar; Raman R Gangakhedkar; Manisha V Ghate; Robert C Bollinger; Sanjay M Mehendale
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

8.  Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.

Authors:  R Ashley-Morrow; J Nollkamper; N J Robinson; N Bishop; J Smith
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

9.  Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.

Authors:  Rhoda Ashley Morrow; David Friedrich; Elizabeth Krantz
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.

Authors:  Jérôme LeGoff; Helen A Weiss; Gérard Gresenguet; Khonde Nzambi; Eric Frost; Richard J Hayes; David C W Mabey; Jean-Elie Malkin; Philippe Mayaud; Laurent Belec
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

View more
  16 in total

1.  Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

Authors:  Hani Al-Shobaili; Khaled M Hassanein; Marwa Salah Mostafa; Ali Saleh Al Duways
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior.

Authors:  Haile Selassie Okuku; Eduard J Sanders; Joyce Nyiro; Caroline Ngetsa; Eric Ohuma; R Scott McClelland; Matthew A Price; Susan M Graham
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

3.  Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread.

Authors:  Charlotte Charpentier; Donato Koyalta; Montana Ndinaromtan; Bagamla Tchobkréo; Mohammad-Ali Jenabian; Nesrine Day; Ali Si-Mohamed; Helen Weiss; Laurent Bélec
Journal:  J Infect Dev Ctries       Date:  2011-02-01       Impact factor: 0.968

4.  Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.

Authors:  Sinéad Delany-Moretlwe; Ute Jentsch; Helen Weiss; Jocelyn Moyes; Rhoda Ashley-Morrow; Wendy Stevens; Philippe Mayaud
Journal:  Sex Transm Infect       Date:  2009-10-16       Impact factor: 3.519

5.  Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India.

Authors:  John A Schneider; Vemu Lakshmi; Rakhi Dandona; G Anil Kumar; Talasila Sudha; Lalit Dandona
Journal:  BMC Infect Dis       Date:  2010-03-09       Impact factor: 3.090

6.  A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya.

Authors:  V Chohan; J M Baeten; S Benki; S M Graham; L Lavreys; K Mandaliya; J O Ndinya-Achola; W Jaoko; J Overbaugh; R S McClelland
Journal:  Sex Transm Infect       Date:  2009-05-19       Impact factor: 3.519

7.  Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.

Authors:  Jérôme LeGoff; Gérard Grésenguet; Chrysostome Gody; Jean De Dieu Longo; Nzambi Khonde; Helen A Weiss; Philippe Mayaud; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2011-05-11

8.  Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya.

Authors:  Joyce U Nyiro; Eduard J Sanders; Caroline Ngetsa; Steve Wale; Ken Awuondo; Elizabeth Bukusi; Matthew A Price; Pauli N Amornkul; D James Nokes
Journal:  BMC Infect Dis       Date:  2011-05-31       Impact factor: 3.090

9.  An Assessment of Risk Factors for Herpes Simplex Virus Type 2 Infection in Malawian Women Using 2 Classifications for the HerpeSelect 2 Test.

Authors:  Payal Chakraborty; Alison H Norris; Sarah Huber-Krum; Sarah Garver; Robert B Hood; Venson Banda; Allahna Esber; Carr Reese Patricia; Robert Krysiak; Abigail Norris Turner
Journal:  Sex Transm Dis       Date:  2020-03       Impact factor: 3.868

10.  Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.

Authors:  Irith De Baetselier; Joris Menten; Vicky Cuylaerts; Khatija Ahmed; Jennifer Deese; Lut Van Damme; Tania Crucitti
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.